MADRIGAL PHARMACEUTICALS, INC. (MDGL) Revenue 2012–2025
MADRIGAL PHARMACEUTICALS, INC. (MDGL) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$958.4MFY2025 · since FY2012: $147,000 → $958.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $958.4M | +432.1% |
| FY2024 | $180.1M | — |
| FY2023 | $0 | — |
| FY2022 | $0 | — |
| FY2021 | $0 | — |
| FY2020 | $0 | — |
| FY2019 | $0 | — |
| FY2018 | $0 | — |
| FY2017 | $0 | — |
| FY2012 | $147,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice